Research Intelligence & Discovery - software & AI news

Daily news on software, AI, and companies shaping research intelligence & discovery.

Showing 37 results
Petri dish with bacterial culture in a dimly lit lab

Aug 10, 2026

Bacterial Trait-Finding and Gene Mapping Platform Speeds Microbial Engineering for Biotech Applications

Researchers at Oak Ridge National Laboratory have developed a novel platform that enhances microbial engineering by identifying genetic triggers that transform bacteria into efficient producers of valuable chemicals and materials.This innovative platform utilizes a blend of synthetic biology, artificial intelligence, and statistical mapping to pinpoint specific genetic factors responsible for complex traits in microbes. This advancement allows for the precise reprogramming of bacteria, potential
A test tube filled with colorful liquid in a laboratory setting.

Aug 7, 2026

Google defectors set up AI-based scientific method company

A new startup, Discovery Loop, has emerged from the ranks of Google DeepMind, founded by prominent AI experts including Jeff Dean, Sanjay Ghemawat, Oriol Vinyals, and Quoc Le. This venture aims to enhance research efficiency in life sciences and various other fields through innovative AI solutions.Discovery Loop's primary focus is on automating the experimental process across diverse disciplines, such as scientific research, drug development, and health informatics. Dean highlighted the team's e
A molecular structure model in a dimly lit lab with research notes.

Aug 7, 2026

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Clarivate has enhanced its Cortellis portfolio with advanced agentic AI capabilities, aiming to transform decision-making in drug development for life sciences organizations.This initiative focuses on integrating AI into existing workflows to streamline research and development processes. By doing so, Clarivate enables R&D teams to expedite drug discovery, enhance safety assessments, and make informed portfolio decisions more swiftly. The Cortellis suite combines reliable life sciences data with
Press release cover image

Aug 4, 2026

YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research

Published in Bioengineering, a collaborative study with Taipei Medical University researchers identifies key molecular candidates to help guide the development of regenerative therapies for corneal disease. TAIPEI, Taiwan, Aug. 04, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today highlighted the publication of a new peer-reviewed study in
Minimalist illustration of a brain and neurons in a dark palette

Jul 21, 2026

The Institute joins AIRIS Project to build an AI Research Collaborator for Biomedical Science

The AIRIS project aims to revolutionize biomedical research by developing an AI platform that integrates mechanistic models of disease.Current generative AI systems often struggle with accurately modeling diseases, as they primarily focus on statistical correlations rather than the biological mechanisms that drive them. This limitation can lead to unreliable predictions, particularly for diseases with poorly understood mechanisms. The AIRIS initiative, involving 21 partners from Europe, the U.S.
abstract representation of biological data

Jul 6, 2026

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models

MindWalk Holdings Corp. has taken a significant step in the AI-driven life sciences sector by filing a European patent for its innovative biological data architecture. This architecture underpins its HYFT® Technology, ReefIQ™, and LensAI™, which are designed to enhance AI models' ability to retrieve and analyze biological data relevant to drug discovery.The patent application focuses on high-dimensional data structures that facilitate the understanding of biological subsequences and property inf
A petri dish with a biological sample in a dimly lit lab setting.

Jul 3, 2026

[Reporter’s Notebook] Korea’s AI-bio race will be won in workflows, not slogans

The emergence of AI in drug discovery is shifting from merely having models to developing integrated scientific workflows that deliver tangible results.At BIO USA 2026, NVIDIA emphasized that the future of AI in drug discovery hinges on its ability to perform genuine scientific tasks rather than just showcasing advanced models. This message was underscored by Anthropic's recent launch of Claude Science, an AI workbench that enables scientists to manage research tasks and analyze data using natur
A petri dish with cultured cells and a research notebook in a dimly lit lab.

Jun 30, 2026

Anthropic releases Claude Science, a product aimed at researchers, the pharma industry

Anthropic has unveiled Claude Science, a new AI application designed specifically for researchers and the pharmaceutical industry.At a recent launch event in San Francisco, Anthropic's CEO Dario Amodei emphasized the potential of Claude Science to navigate the intricate challenges of biological research. He noted that, while traditional methods have relied heavily on human cognition, the integration of AI could enhance our understanding of complex biological systems. Amodei acknowledged that bio
A minimalist illustration of a brain with circuit patterns, representing AI in life sciences.

Jun 30, 2026

The Briefing: AI for Science

The integration of AI in life sciences is poised to revolutionize scientific discovery, contingent upon strategic development and collaboration.Currently, biologists often juggle multiple disconnected tools and databases, a situation that has historically slowed down scientific progress. However, a shift is underway as pharmaceutical companies, biotech firms, and research institutions begin to adopt AI solutions like Claude. This technology is streamlining research processes, reducing timelines
A flat illustration of a protein structure in a minimalist style.

Jun 28, 2026

NVIDIA (NVDA) Launches BioNeMo Agent Toolkit to Accelerate AI-Driven Scientific Discovery in Life Sciences

NVIDIA has launched the BioNeMo Agent Toolkit, a software suite aimed at enhancing AI-driven scientific discovery in the life sciences sector.This new toolkit integrates over ten years of NVIDIA's advancements in libraries and models, equipping AI systems with tools for complex tasks such as protein design, molecular docking, and genomic analysis. Essentially functioning as a "scientific toolbox," it allows AI agents to gather data, reason through findings, and conduct computational experiments,
A petri dish with T cells in a dimly lit lab setting.

Jun 25, 2026

Immunai Signs Discovery Deal With Boehringer Ingelheim

Immunai, an AI-driven biotech company based in Israel, has entered into a significant discovery collaboration with Boehringer Ingelheim, a major German pharmaceutical firm. This partnership is valued at up to $15 million and is scheduled to continue through 2027.The collaboration will leverage Immunai's advanced single-cell AI platform to analyze T cells from a vast array of patient samples related to cancer and autoimmune diseases. The goal is to uncover common patterns of T-cell dysfunction th
A minimalist illustration of a test tube and microscope in a lab setting.

Jun 18, 2026

OpenAI launches LifeSciBench to evaluate AI in life sciences

OpenAI has introduced LifeSciBench, a robust benchmarking tool designed to assess AI models in real-world life sciences research environments.This new tool, launched on June 17, consists of 750 expert-developed tasks that encompass the complexities of biological research workflows, moving beyond simplified textbook scenarios. The tasks cover seven key workflows including evidence handling, scientific reasoning, and communication, reflecting the multifaceted nature of daily research conducted by